Literature DB >> 12383943

Increased dopamine peroxidation in postmortem Parkinsonian brain.

Angela De Iuliis1, Alessandro P Burlina, Roberta Boschetto, Pamela Zambenedetti, Paola Arslan, Lauro Galzigna.   

Abstract

We have previously reported the presence, in human midbrain, of an enzymatic activity which catalyzes the formation of dopaminochrome from dopamine (DA) and hydrogen peroxide. Here, we report, for the first time, an increased DA peroxidizing activity in the midbrain and basal ganglia of autoptic Parkinsonian brains. The crude activity was determined spectrophotometrically in extracts of paraffin-embedded slices obtained from autopsied brain. No addition of substrate was necessary since endogenous substrates such as DA and hydrogen peroxide were present in the samples. In Parkinson's patients' midbrain, this activity was substantially increased compared to normal midbrain. Moreover, the DA peroxidizing activity, which was absent in basal ganglia of normal people, was detectable in all our Parkinson's patients. These observations suggest that a peroxidizing pathway of DA may be present in human brain. The increased peroxidizing activity in Parkinson's patients generates the toxic compound dopaminochrome which may play a role in the pathogenesis of this disease.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12383943     DOI: 10.1016/s0304-4165(02)00331-8

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  6 in total

Review 1.  Ceruloplasmin and what it might do.

Authors:  J Healy; K Tipton
Journal:  J Neural Transm (Vienna)       Date:  2007-04-04       Impact factor: 3.575

2.  Myeloperoxidase and Advanced Oxidation Protein Products in the Cerebrospinal Fluid in Women and Men with Parkinson's Disease.

Authors:  Emilio Fernández-Espejo; Fernando Rodríguez de Fonseca; Ana Luisa Gavito; Antonio Córdoba-Fernández; José Chacón; Ángel Martín de Pablos
Journal:  Antioxidants (Basel)       Date:  2022-05-30

3.  Extracellular dopamine potentiates mn-induced oxidative stress, lifespan reduction, and dopaminergic neurodegeneration in a BLI-3-dependent manner in Caenorhabditis elegans.

Authors:  Alexandre Benedetto; Catherine Au; Daiana Silva Avila; Dejan Milatovic; Michael Aschner
Journal:  PLoS Genet       Date:  2010-08-26       Impact factor: 5.917

Review 4.  Catecholamine autotoxicity. Implications for pharmacology and therapeutics of Parkinson disease and related disorders.

Authors:  David S Goldstein; Irwin J Kopin; Yehonatan Sharabi
Journal:  Pharmacol Ther       Date:  2014-06-16       Impact factor: 12.310

5.  Glutathione Peroxidase 4 is associated with Neuromelanin in Substantia Nigra and Dystrophic Axons in Putamen of Parkinson's brain.

Authors:  Frederick P Bellinger; Miyoko T Bellinger; Lucia A Seale; Andrea S Takemoto; Arjun V Raman; Takanori Miki; Amy B Manning-Boğ; Marla J Berry; Lon R White; G Webster Ross
Journal:  Mol Neurodegener       Date:  2011-01-21       Impact factor: 14.195

Review 6.  Iron as the concert master in the pathogenic orchestra playing in sporadic Parkinson's disease.

Authors:  P Riederer; C Monoranu; S Strobel; T Iordache; J Sian-Hülsmann
Journal:  J Neural Transm (Vienna)       Date:  2021-10-12       Impact factor: 3.575

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.